Nature Reviews Urology

Article	Citations
Sexual recovery interventions following prostate cancer treatment	187
Novel intravesical gemcitabine delivery system (TAR-200) for neoadjuvant treatment of MIBC: context is everything	170
Texture analysis for patient selection	150
Single-cell and spatial sequencing of kidney cancer	120
Human-relevant urothelial model provides insight into infection strategies and host response	102
Krause corpuscles act as genital vibration detectors	81
Immune infiltration associated with outcomes	71
Semen quality recovery following COVID-19	68
PARP inhibitors plus enzalutamide to treat mCRPC	67
Top, bottom or vers? Creating a more equitable health system for sexual and gender minority patients with prostate cancer	66
Urine microbiota differ in bladder cancer	66
Micro-ultrasound for prostate cancer	65
Advancing the state of the art in congenital obstructive uropathy	64
Considering urology in a planetary context	62
Implementation of patient-reported outcome measures into health care for men with localized prostate cancer	59
Time for women-centred gynaecology	58
A clinical guide to rare male sexual disorders	58
Preclinical models of bladder cancer: BBN and beyond	58
High-dose chemotherapy for relapsed testicular germ cell tumours	55
Proteomic-based analysis of testicular interstitial fluid	52
Prevalence of gender dysphoria in Japan	50
FOXA2–KIT-driven lineage plasticity in NEPC	50
A new text message-based platform for self-management of patients with IC/BPS	50
Overcoming antibiotic resistance in complicated UTI	46
Is SARS-CoV-2-induced testicular damage in hamsters relevant?	43

Madrid plays host to a celebration of urology	42
Promise without practice — charting the path forward for bladder cancer biomarkers	42
Evolution of the World Health Organization semen analysis manual: where are we?	42
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers	40
Microfluidic sperm selection	40
What happens in Vegas … shapes the future of urology	40
The evolving landscape of monogenic nephrolithiasis and therapeutic innovations	39
Antibiotic therapy for treating overactive bladder is not supported by clinical evidence	39
Galectins as potential therapeutic targets in STIs in the female genital tract	39
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer	39
Metaverse in surgery — origins and future potential	39
Pembrolizumab + axitinib beyond first-line therapy for mRCC	38
COVID can’t kill CopMich collaboration	37
A non-invasive assay for UTUC diagnosis	37
Resolving the puzzle of same-sex sexual interactions	36
Vaccination to prevent untreatable gonorrhoea	36
Bioinformatics in urology — molecular characterization of pathophysiology and response to treatment	34
PEACEing together prostate cancer therapy	33
Efficacy of the Revi system in treating urgency urinary incontinence	33
The mechanism of action of neuromodulation in the treatment of overactive bladder	33
Quest for a genetic biomarker for sickle cell disease priapism: rationale, progress and implications	33
EMUC25: shaping tomorrow’s uro-oncology care	32
Personalized 3D models for prostate cancer surgery	32
Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway	32
Persistent Müllerian duct syndrome — a rare but important cause of male factor infertility	32
Pain management in percutaneous nephrolithotomy — an approach rooted in pathophysiology	30
Measuring and improving the cradle-to-grave environmental performance of urological procedures	30
Sexual orientation, gender identity and COVID: a complicated picture	28
The magic of MagSToNE	27
Author Correction: Can PROMs improve racial equity in outcomes after prostatectomy?	27
Cribriform morphology affects mpMRI imaging	27
Rucaparib improves PFS in patients with BRCA1/2-altered mCRPC	27
Secondary kidney stones — remove or leave?	27
Effect of high glucose on E. coli	27
Women in urology: the past	25
A distinct TAM subset mediates immunotherapy resistance in prostate cancer	25
Excluding PLND in favourable intermediate-risk prostate cancer: a PSMA-PET-directed perspective	24
Successful mentorship for women in urology — a new era	24
Prostate cancer in transgender women — challenges in research and clinical care	24
Promising efficacy of UTI vaccines as an alternative to antibiotics	24
AUA returns to its former glory in Chicago	24
Robots learning to imitate surgeons — challenges and possibilities	23
Is it time to rethink the current patient-reported outcome measures?	22
Microultrasonography-guided prostate cancer biopsy	21
Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease	20
Technical modifications to improve erectile function recovery after radical prostatectomy	19
Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer	19
Videourodynamics — role, benefits and optimal practice	19
Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards	18
A clinical overview of people living with HIV and genitourinary cancer care	18

Current and emerging strategies to curb antibiotic-resistant urinary tract infections	18
Going in circles: circMGA–HNRNPL feedback loop in bladder cancer	17
Androgen receptor pathway inhibitor combination in prostate cancer	17
Management and cost of stent encrustation in pregnancy	16
Detecting lymph node metastases for personalized radiotherapy in patients with prostate cancer	16
AI for antibiotic design	15
Immune-based therapies in penile cancer	15
Pride, not prejudice	15
De-clear cell differentiated renal cell carcinoma — a new therapeutic target	15
Turning up the heat: CTLA4 blockade in urothelial cancer	15
The future of patient-derived xenografts in prostate cancer research	14
The evolving treatment landscape of metastatic urothelial cancer	14
Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective	13
Overall survival with adjuvant pembrolizumab in renal cell carcinoma — the shock of the lightning	13
Evolving language reflects evolving understanding: updated terms for anatomical description in i/VSC/DSD	13
The prognostic role of stroma in UTUC	13
The value of women urologists — individual and institutional imperatives to address salary equity	12
The unclear role of PET–CT in localized radiorecurrent prostate cancer	12
Uncovering a link between COVID-19 and renal cell carcinoma	12
Turning back time in the testes	12
We all get erections — de-gendering sexual arousal dysfunction in the ICD	12
Hallmark discoveries in the biology of Wilms tumour	12
New evidence and novel techniques for assessing intraoperative margins during radical prostatectomy	11
Breaking the silence: normalizing receptive anal intercourse for patients, for people and for myself	11
The shifting treatment paradigm of metastatic renal cell carcinoma	11
Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer	11
Pelvic-fascia-sparing techniques and outcomes with RARP	11
Current and future pharmacotherapy for female sexual dysfunction	11
Och AI the noo from SIU	11
Vitamins as regulators of calcium-containing kidney stones — new perspectives on the role of the gut microbiome	10
CMA mediates resistance to androgen inhibitors in prostate cancer	10
Improved phenotypic classification of male infertility to promote discovery of genetic causes	10
BAUSing back in Birmingham	10
Power up to investigate PrEP	10
Effects of COVID-19 vaccine on semen parameters	10
Men hold the balance of power	10
Patient selection is key in IMbassador250	9
Metabolism, mitochondria and metastasis in kidney cancer	9
ARNEO: neoadjuvant degarelix + apalutamide before surgery for high-risk prostate cancer	9
Diagnosis of ccRCC	9
Tuft cells in prostate cancer	9
MRI diagnosis and radical prostatectomy outcomes	8
Spatiotemporal trends in human semen quality	8
Author Correction: Atypical intraductal proliferation in prostate biopsy — a diagnostic grey zone with clinical implications	8
Semen parameters across testicular cancer stages	8
Mechanisms of the intestinal and urinary microbiome in kidney stone disease	8
Male infertility and somatic health — insights into lipid damage as a mechanistic link	8
The ins and outs of penile erection	8
A prompt-based stewardship to reduce extended-spectrum antibiotic treatment in UTI	8
Microbiota manipulation to prevent oxalate kidney stone formation	8
Mellow yellow: BilR reduces bilirubin to urobilinogen	8
Sperm activity affected by endometriosis	7
Advances in sliding clip renorrhaphy for partial nephrectomy	7
Pathophysiology and potential multimodal therapeutic strategies for IC/BPS	7
Particulate matter leaves a bitter taste in testes	7
Chlorination by-products in drinking water — association with bladder cancer risk	7
Toilet-based continuous health monitoring using urine	7
Prostate luminal progenitor cells: from mouse to human, from health to disease	7
Syphilis on the rise — a need for alternative therapies and vaccines	7
Pronouns in English: a user’s guide	7
Stepping up to prevent bacterial vaginosis recurrence	7
Testosterone replacement therapy and spermatogenesis in reproductive age men	7
Clinical trial design for non-muscle-invasive bladder cancer	6
The future of pelvic lymph node dissection for urological malignancies	6
Visual clues — dermatological manifestations of sexually transmitted infections in men	6
Genetic and biological drivers of prostate cancer disparities in Black men	6
Feasibility and potential of an MRI-based prostate cancer screening	6
ADT intensification to treat biochemically recurrent prostate cancer	6
Von Hippel–Lindau protein signalling in clear cell renal cell carcinoma	6
Artificial intelligence in the management of prostate cancer	6
The effects of diet on prostate cancer outcomes	6
Urology on a changing planet: links between climate change and urological disease	6
A great gathering at the 4th Clinical and Scientific Advances in UTI conference	6
Influence of substance use on male reproductive health and offspring outcomes	6
Mutagenic effect of chemotherapy on sperm DNA and implications for family planning	5
Exploring the impact of lipid stress on sperm cytoskeleton: insights and prospects	5
Gut microbiome’s effect on immunotherapy response	5
Reply to ‘Management of very young fetuses with LUTO’	5
The prostatic middle lobe: clinical significance, presentation and management	5
Being a non-native English speaker in science and medicine	5

Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma	5
An app for optimizing UTI screening	5
Improving care for transgender and non-binary individuals	5
Pregnancy and parental leave in medicine and academia — a focus on urology	5
Prescribing clinician specialty influences adherence to PrEP	5
New insights into APOBEC-mediated mutagenesis in prostate cancer	5
Sexual transfer of bacteria for forensic use	5
GDF15 blockade can reduce immunotherapy resistance in urothelial cancer	4
Managing autonomic dysreflexia during urological care in individuals living with spinal cord injury	4
Prostate cancer epigenetics — from pathophysiology to clinical application	4
Iatrogenic upper urinary tract injuries during ureteroscopy for urolithiasis: a comprehensive review on incidence, mechanisms and preventative strategies	4
A urologist as a urological patient	4
Should we screen for sleep apnoea in men with idiopathic infertility?	4
Advancing perioperative care in MIBC: insights from NIAGARA	4
Non-human primates as a translational model for the study of male reproductive health	4
Patient-reported outcomes in metastatic renal cell carcinoma trials using combinations versus sunitinib as first-line treatment	4
Landmarks in the evolution of prostate biopsy	4
A vagina on a chip to model microbiome–host interactions	4
Understanding and integrating cytoreductive nephrectomy with immune checkpoint inhibitors in the management of metastatic RCC	3
Metabolic alterations drive enzalutamide resistance	3
Urinary microbiota associated with OAB symptoms	3
Metastasis development in non-muscle-invasive bladder cancer	3
CRISPR–Cas9 potential for identifying novel therapeutic targets in muscle-invasive bladder cancer	3
Bladder EpiCheck for NMIBC	3
Immunoliposome targeting IL-30	3
The opportunities and barriers for developing tumour-infiltrating lymphocyte therapy for patients with advanced genitourinary cancers	3
Generative AI in scientific publishing: disruptive or destructive?	3
Proteomic characterization of bladder cancer	3
Perspectives on chemsex	3
Can systematic biopsy be omitted from the prostate cancer diagnostic pathway?	3
Promoting the health of men of all backgrounds: educating ourselves to build trust and improve care	3
PIONEER big data platform for prostate cancer: lessons for advancing future real-world evidence research	3
The testosterone paradox of advanced prostate cancer: mechanistic insights and clinical implications	3
The effect of red blood cell disorders on male fertility and reproductive health	3
Exercise, diet and psychological support for patients with testicular cancer	3
The potential role of the microbiota in prostate cancer pathogenesis and treatment	3
Mapping the human prostate at the cellular level	3
From foes to friends: rethinking the role of lymph nodes in prostate cancer	3
Emerging evidence for sequencing and combining PSMA-based therapies in prostate cancer	3
Clinical hypnosis improves LUTS	3
Author Correction: Advances in sliding clip renorrhaphy for partial nephrectomy	3
Optimizing cystoscopy and TURBT: enhanced imaging and artificial intelligence	3
Sex differences in bladder cancer: emerging data and call to action	3
A new surgical procedure to treat BPH	3
Health-related quality of life after curative treatment for muscle-invasive bladder cancer	3
Human sperm RNA in male infertility	3
Knockout of extended pelvic lymph node dissection during radical cystectomy	3
Experimental in vitro, ex vivo and in vivo models in prostate cancer research	2
UPEC-mediated alteration of host mitochondrial function — a survival strategy	2
Microplastics in the penis	2
Utility of PSA screening in transgender women receiving oestrogens	2
Supplementary selenium and vitamin E in non-muscle-invasive bladder cancer	2
The dynamic roles of the bladder tumour microenvironment	2
Artificial intelligence in academic writing: a paradigm-shifting technological advance	2
The burden of kidney transplant evaluation — an older adults’ perspective	2
Metabolic flexibility in ccRCC	2
Body fluid-derived stem cells — an untapped stem cell source in genitourinary regeneration	2
Focusing on male infertility	2
20 years of ‘spilling the tea’ in urology	2
Accessing information in the AI age	2
Evolving the surgical approach for bladder cancer — robotic versus open radical cystectomy	2
Targeting TGCT	2
Molecular and therapeutic landscape of non-clear cell renal carcinoma	2
PROTACs for prostate cancer	2
WGC in patients with localized prostate cancer	2
Digital twins for personalized treatment in uro-oncology in the era of artificial intelligence	2
Patient-reported toxic effects of hypofractionated versus conventional RT	2
Intravesical ICIs to reduce toxicity in NMIBC	2
Abortion is a urology workforce issue	2
NMIBC risk factors in patients treated with BCG	2
Control of oncogenic signalling in ccRCC	2
Effects of the environment on the evolution of the vertebrate urinary tract	2
Robotic kidney transplantation	2
Adjuvant personalized cancer vaccine: is this the end of metastatic kidney cancer	2
AI for drug discovery	2
A new signalling-based system for germ cell reprogramming	1
PSMA-PET to detect prostate cancer recurrence after radiotherapy	1
Intralesional heterogeneity on PSMA PET–CT predicts mCRPC outcomes	1
Relationships between holmium laser enucleation of the prostate and prostate cancer	1
Urine biomarkers in bladder cancer — current status and future perspectives	1
Therapeutic targeting of prostate-specific membrane antigen could limit its potential as benchmark imaging	1
Embryonal origin of adult testicular macrophages	1
Biomarkers of disease recurrence in stage I testicular germ cell tumours	1
Understanding and managing the cardiovascular risks of androgen deprivation therapy for prostate cancer	1
Gender differences in burnout among urologists	1
Interactions between androgen and IGF1 axes in prostate tumorigenesis	1
Reply to ‘The disruption of circadian rhythm as a potential mechanism of nocturia-like symptoms — a paediatric urology perspective’	1
Immunoproteasome inhibition in CRPC	1
Road for inclusion and caring in urology starts at AUA 22	1
Treatment de-escalation for stage II seminoma	1
Melon seed extract protects against testis metal toxicity	1
20 years of taxane therapy in prostate cancer — the past, present and future	1
Temporary cessation versus continued TKI therapy for RCC	1
First-morning urine samples to study the urobiome	1
ML-guided decision for patient discharge location	1